Table 4.
Multimorbidity and Bivariate Associations with Guideline Concordant Colorectal Cancer Screening
| Number of Morbidities | Colonoscopy screening |
Any guideline concordant screening |
|||||
|---|---|---|---|---|---|---|---|
| N | % Subjects | N | % Screened† | N | % Screened† | ||
| No morbidities | 87 | 7.9 | 86 | 50.0 | 85 | 56.5 | |
| 1 morbidity | 163 | 14.8 | 163 | 52.8 | 159 | 59.1 | |
| 2–3 morbidities | 413 | 37.6 | 411 | 61.6‡ | 408 | 65.7 | |
| 4–5 morbidities | 277 | 25.2 | 276 | 64.5 | 274 | 70.8‡ | |
| 6+ morbidities | 159 | 14.5 | 158 | 69.6‡ | 157 | 79.6§ | |
| Total* | 1099 | 100.0 | 1,147 | 1,134 | |||
*
Number of observations varies due to sporadically missing data.
†
Percentage of respondents who reported a guideline-concordant screening.
‡
§Statistically significant difference among each level of morbidities and CRC screening with Chi-square test of independence or Fisher’s exact, p < 0.05. Chi-square partitioning was conducting for the statistically significant relationships between a CRC screening modality and number of morbidities.
§
Statistically significant difference, p < 0.01 based on the results of chi-square partitioning (i.e., using likelihood ratio chi-squared statistics).